Reverba

"High-tech capabilities are the “secret sauce” for driving the human touch." Pssst... we've been sharing this secret to our sauce for 20 years and counting😉

High-touch, tech-enabled patient engagement + patient activation resolve barriers to accessing care The years ahead will require the ongoing enactment of meaningful policy, ongoing research and investment, and foresighted dedication to innovative solutions and technical advancements that support patient engagement and activation.

Limitations on how we enable people to identify create limitations on the resources they get access to. It's time to do better for the 15% (and growing) population in America.

I Don't Have a Box Is it possible for resources to be shared among underrepresented racial and ethnic groups when their identity on forms still doesn’t exist?

Helping patients invest in life sciences companies is an interesting strategy. We're going to stick with helping life sciences companies invest in patients.

Why a consulting firm focused life sciences bought a healthcare crowdsourcing platform Alira Health hopes its purchase of RedCrow will help it stand out from the crowd of consulting firms that help life sciences companies bring drugs to market.

Optimizing is how clinical trial organizers and sponsors can address two of their biggest challenges: recruiting qualified participants and reducing drop outs - find out how.

Reach Endpoints Faster: How Successful Clinical Trials Optimize… Learn how to recruit participants faster and provide a better experience by optimizing patient engagement for your clinical trial.

T-cell therapy is a revolutionary cancer treatment. It's also difficult to access for roughly HALF of Americans, because they live more than 30 minutes from the nearest transplant center. We need to better at engaging and providing for rural populations.

Rural Americans have difficulty accessing a promising cancer treatment After settling in rural New Mexico, a cancer patient had to move 750 miles east and live in a trailer to access CAR-T treatment at the MD Anderson Cancer Center.

"Too often, the sphere of innovation eclipses the communities in greatest need.” Not this time. Finally, some GOOD news!

Meet the 7 startups UCLA Health selected for its health equity accelerator UCLA Health recently announced the inaugural cohort of startups for its health equity accelerator. The seven digital health startups, which represent pre-seed through Series A-stage companies, are developing digital health solutions to address chronic disease management, respiratory illness and heal...

Data is powerful. With great power comes great responsibility. Spiderman learned this lesson the hard way - choose the right partner and you won't have to. 🕸

Meta is being sued for giving US hospitals a data-tracking tool that allegedly ended up disclosing patient information to Facebook A second lawsuit alleges hospitals violated HIPAA by providing private patient data to Meta that it sometimes then used in personalized Facebook ads.

“Give me the chance to say no after I’ve received all the information. Let me make that informed decision. Nobody’s telling us about clinical trials. Why is that?”

FDA and drug makers deepen their commitment to clinical-trial diversity. Will it work? After years of ‘lackluster’ efforts, regulators and companies are finally aligned in their goal to make clinical trials more representative of U.S. population.

More time with physicians = more engaged patients. How much time docs spend with patients has been increasing steadily for 40 years, but like most things, these gains are not shared equally by people of color. Let's spend more time figuring out why and changing that.

Docs Spend More Time with Patients, but Racial Disparities Still Present The amount of time physicians spend with patients each year has increased, but racial disparities in physician face time have gotten worse, potentially furthering other racial health disparities.

Our mission centers around better health outcomes for all, so we stand with the community in celebrating . It's a privilege to amplify your health experiences.

40%. That's the percentage of cancer trials failing to reach targets for accrual. The solution comes down to improving the and making smarter, decisions.

Lack of diversity in clinical trials isn’t just a recruiting problem—it’s a data problem To achieve diversity goals in research requires a multifaceted approach that makes clinical trial participation easier and uses analytics to help identify the right patients to recruit for a clinical trial.